Publication | Closed Access
Clinical Activity of Trastuzumab and Vinorelbine in Women With HER2-Overexpressing Metastatic Breast Cancer
368
Citations
23
References
2001
Year
Trastuzumab in combination with vinorelbine is highly active in women with HER2-overexpressing advanced breast cancer and is well tolerated.
| Year | Citations | |
|---|---|---|
Page 1
Page 1